This is a single case report of a 61-year-old man with a 20-year smoking history who was diagnosed with primary pulmonary mucoepidermoid carcinoma (PMEC), a rare type of lung cancer. The report describes his tumor's features in detail.
Doctors found that the tumor had a CRTC1-MAML2 gene fusion, which is a genetic change often seen in this type of cancer. They also found no common driver mutations like EGFR or KRAS. The tumor did not have PD-L1 expression, and its mutational burden was low. The Ki-67 level was 7%, which is a marker of how fast cells are dividing.
Because this is only one case, the findings cannot be generalized to all patients with PMEC. The report suggests the tumor may be low-grade with a relatively favorable prognosis, but this is based on a single patient. No safety or treatment information was reported.
Readers should understand that this is early, limited evidence. It may help doctors recognize this rare cancer, but it does not change treatment guidelines or provide proof of what works best. Anyone with questions about their own diagnosis should talk to their doctor.
Common questions
What is primary pulmonary mucoepidermoid carcinoma?
It is a rare type of lung cancer. This case report describes one man with this diagnosis. The tumor had a CRTC1-MAML2 gene fusion and low Ki-67, which may suggest a low-grade tumor. Because it is so rare, most information comes from individual cases like this one.
Is this cancer hereditary?
The report does not say whether this cancer runs in families. It only describes one patient. The CRTC1-MAML2 fusion is a genetic change found in the tumor itself, not necessarily an inherited one. Talk to your doctor if you have concerns about family risk.
What does a low Ki-67 mean?
Ki-67 is a marker that shows how fast cells are dividing. In this case, it was 7%, which is considered low. The report suggests this may indicate a low-grade tumor with a relatively favorable prognosis. However, this is based on a single patient, so it cannot be applied to everyone.
Does this change how this cancer is treated?
No. This is a single case report, so it does not provide evidence that any treatment works better. It may help doctors recognize the disease, but treatment decisions should be based on guidelines and discussions with your care team. Always consult your doctor about your own situation.
